SCHEMBL485077

SCHEMBL485077

CC[C@@](C)(N)C(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2028469 1.00 — —
SCHEMBL485564 1.00 — —
Hydrochloric Acid SCHEMBL4390742 0.98 DGAT1 (0.43) —
Hydrochloric Acid SCHEMBL485076 0.98 DGAT1 (0.43) —
Hydrochloric Acid SCHEMBL30832452 0.98 DGAT1 (0.43) —
Hydrochloric Acid SCHEMBL485563 0.98 DGAT1 (0.43) —
Hydrochloric Acid SCHEMBL485078 0.98 DGAT1 (0.43) —
Iodomethane SCHEMBL7525092 0.95 DGAT1 (0.41) —
SCHEMBL16297377 0.82 ALDH1A1 (0.32) —
SCHEMBL2304603 0.81 LMNA (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8048912-B2 Benzopyran derivatives having inhibitory activities against liver fibrosis and cirrhosis and their pharmaceutical uses SK CHEMICALS CO., LTD. (KR) 2011-11-01 — — US claimed
US-20090118302-A1 Novel Benzopyran Derivatives Having Inhibitory Activities Against Liver Fibrosis and Cirrhosis and Their Pharmaceutical Uses KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2009-05-07 — — US claimed
WO-2006070984-A1 NOVEL BENZOPYRAN DERIVATIVES HAVING INHIBITORY ACTIVITIES AGAINST LIVER FIBROSIS AND CIRRHOSIS AND THEIR PHARMACEUTICAL USES SK CHEMICALS, CO., LTD. (KR) 2006-07-06 — — WO claimed
EP-3141548-B9 PROCESSES AND INTERMEDIATES FOR PRODUCING AZAINDOLES VERTEX PHARMA (US) 2020-08-12 — — EP disclosed
EP-3141548-B1 PROCESSES AND INTERMEDIATES FOR PRODUCING AZAINDOLES VERTEX PHARMA (US) 2020-04-08 — — EP disclosed
US-20180021336-A1 IMIDAZOLIDINEDIONE DERIVATIVES AUTIFONY THERAPEUTICS LIMITED (GB) 2018-01-25 — — US disclosed
US-9849131-B2 Imidazolidinedione derivatives AUTIFONY THERAPEUTICS LIMITED (GB) 2017-12-26 — — US disclosed
CN-104185477-B Cytotoxic peptides and antibody-drug conjugates thereof 辉瑞公司 2017-05-24 — — CN disclosed
EP-3141548-A1 PROCESSES AND INTERMEDIATES FOR PRODUCING AZAINDOLES Vertex Pharmaceuticals Incorporated (US) 2017-03-15 — — EP disclosed
US-20170065585-A1 IMIDAZOLIDINEDIONE DERIVATIVES GLAXO GROUP LIMITED (GB) 2017-03-09 — — US disclosed
US-20170065585-A1 IMIDAZOLIDINEDIONE DERIVATIVES GLAXO GROUP LIMITED (GB) 2017-03-09 — — US disclosed
US-20090118302-A1 Novel Benzopyran Derivatives Having Inhibitory Activities Against Liver Fibrosis and Cirrhosis and Their Pharmaceutical Uses KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2009-05-07 — — US disclosed
US-20080090854-A1 CXCR2 INHIBITORS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-04-17 — — US disclosed
US-20080090854-A1 CXCR2 INHIBITORS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-04-17 — — US disclosed
US-20080090854-A1 CXCR2 INHIBITORS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-04-17 — — US disclosed
EP-1836158-A1 FUSED BICYCLIC CARBOXAMIDE DERIVATIVES FOR USE AS CXCR2 INHIBITORS IN THE TREATMENT OF INFLAMMATION Sanofi-Aventis Deutschland GmbH (DE) 2007-09-26 — — EP disclosed
WO-2006070984-A1 NOVEL BENZOPYRAN DERIVATIVES HAVING INHIBITORY ACTIVITIES AGAINST LIVER FIBROSIS AND CIRRHOSIS AND THEIR PHARMACEUTICAL USES SK CHEMICALS, CO., LTD. (KR) 2006-07-06 — — WO disclosed
WO-2006069656-A1 FUSED BICYCLIC CARBOXAMIDE DERIVATIVES FOR USE AS CXCR2 INHIBITORS IN THE TREATMENT OF INFLAMMATION SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2006-07-06 — — WO disclosed
CN-1089549-C N-acetonylbenzamide fungicides DOW AGRICULTURE CO LTD (US) 2002-08-28 — — CN disclosed
CN-1173278-A N-acetonylbenzamide fungicides ROHM & HAAS (US) 1998-02-18 — — CN disclosed
Send feedback